Eu­ro­pean in­vestor Early­bird Health clos­es $185M fund to back 12 to 15 com­pa­nies

Ger­many-based in­vestor Early­bird Health has closed its sec­ond health­care-fo­cused fund and has al­ready de­ployed some of it in bio­phar­ma and medtech com­pa­nies, with one ex­it in the books and an­oth­er in sight, part­ner Flo­rent Gros told End­points News.

Early­bird’s €173 mil­lion (about $185 mil­lion) sec­ond fund comes on the heels of mul­ti­ple oth­er VC fund hauls dis­closed in re­cent weeks at the likes of The Col­umn Group, Scion Life Sci­ences and oth­ers. It is sig­nif­i­cant­ly larg­er than the firm’s first health­care-ded­i­cat­ed fund from 2016 that closed at €85 mil­lion. British Pa­tient Cap­i­tal and BARMER, a pub­lic health in­sur­er in Ger­many, were some of the in­vestors in the new fund.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER